Combined Effects of Curcumin and Triptolide on an Ovarian Cancer Cell Line

  • Cai, Ying-Ying (Department of Obstetrics and Gynecology, Wenling City Chinese Medicine Hospital) ;
  • Lin, Wei-Ping (Department of Obstetrics and Gynecology, Wenling City Chinese Medicine Hospital) ;
  • Li, Ai-Ping (Department of Obstetrics and Gynecology, Wenling City Chinese Medicine Hospital) ;
  • Xu, Jian-Yang (Department of Obstetrics and Gynecology, Wenling City Chinese Medicine Hospital)
  • Published : 2013.07.30


Background: As natural medicines in Asia, curcumin and triptolide extracted from different drug plants have proven to possess anticancer potential and widely used for anti-cancer research. The present study attempted to clarify that curcumin and triptolide synergistically suppress ovarian cancer cell growth in vitro. Methods: To test synergic effects, cell viability and apoptosis were analyzed after curcumin and triptolide combination treatment on ovarian cancer cell lines. Synergistic effects on apoptosis induction were determined by lactate dehydrogenase (LDH) leakage assay, intracellular reactive oxygen species (ROS) assay, mitochondrial membrane potential (MMP) loss assay and flow cytometry analysis. Critical regulators of cell proliferation and apoptosis related were analyzed by qRT-PCR and Western blotting. Results: We showed that the combination of curcumin and triptolide could synergistically inhibit ovarian cancer cell growth, and induce apoptosis, which is accompanied by HSP27 and HSP70, indicating that HSP27 and HSP70 play the important role in the synergic effect. Conclusions: From the result present here, curcumin and triptolide combination with lower concentration have a synergistic anti-tumor effect on ovarian cancer and which will have a good potential in clinical applications.


Curcumin;triptolide;ovarian cancer cell line;cytotoxicity


  1. Antonoff MB, Chugh R, Borja-Cacho D, et al (2009). Triptolide therapy for neuroblastoma decreases cell viability in vitro and inhibits tumor growth in vivo. Surgery, 146, 282-90.
  2. Antonoff MB, Chugh R, Skube SJ, et al (2010). Role of Hsp-70 in triptolide-mediated cell death of neuroblastoma. J Surg Res, 163, 72-8.
  3. Banjerdpongchai R, Wilairat P (2005). Effects of water-soluble antioxidants and MAPKK/MEK inhibitor on curcumininduced apoptosis in HL-60 human leukemic cells. Asian Pac J Cancer Prev, 6, 282-5.
  4. Blakemore LM, Boes C, Cordell R, Manson MM (2013). Curcumin-induced mitotic arrest is characterized by spindle abnormalities, defects in chromosomal congression and DNA damage. Carcinogenesis, 34, 351-60.
  5. Borja-Cacho D, Yokoyama Y, Chugh RK, et al (2010). TRAIL and triptolide: an effective combination that induces apoptosis in pancreatic cancer cells. J Gastrointest Surg, 14, 252-60.
  6. Clawson KA, Borja-Cacho D, Antonoff MB, Saluja AK, Vickers SM (2010). Triptolide and TRAIL combination enhances apoptosis in cholangiocarcinoma. J Surg Res, 163, 244-9.
  7. Du Q, Hu B, An HM, et al (2013). Synergistic anticancer effects of curcumin and resveratrol in Hepa1-6 hepatocellular carcinoma cells. Oncol Rep, 29, 1851-8.
  8. Dudeja V, Mujumdar N, Phillips P, et al (2009). Heat shock protein 70 inhibits apoptosis in cancer cells through simultaneous and independent mechanisms. Gastroenterology, 136, 1772-82.
  9. Gandhy SU, Kim K, Larsen L, Rosengren RJ, Safe S (2012). Curcumin and synthetic analogs induce reactive oxygen species and decreases specificity protein (Sp) transcription factors by targeting microRNAs. BMC Cancer, 12, 564.
  10. Hsu SF, Chao CM, Huang WT, Lin MT, Cheng BC (2013). Attenuating heat-induced cellular autophagy, apoptosis and damage in H9c2 cardiomyocytes by pre-inducing HSP70 with heat shock preconditioning. Int J Hyperthermia, 29, 239-47.
  11. Huang M, Zhang H, Liu T, et al (2013). Triptolide inhibits MDM2 and induces apoptosis in acute lymphoblastic leukemia cells through a p53-independent pathway. Mol Cancer Ther, 12, 184-94.
  12. Jiang M, Huang O, Zhang X, et al (2013). Curcumin induces cell death and restores tamoxifen sensitivity in the antiestrogenresistant breast cancer cell lines MCF-7/LCC2 and MCF-7/ LCC9. Molecules, 18, 701-20.
  13. Kaufmann SH, Earnshaw WC (2000). Induction of apoptosis by cancer chemotherapy. Exp Cell Res, 256, 42-9.
  14. Khaw AK, Hande MP, Kalthur G, Hande MP (2013). Curcumin inhibits telomerase and induces telomere shortening and apoptosis in brain tumour cells. J Cell Biochem, 114, 1257-70.
  15. Kim MJ, Lee TH, Kim SH, et al (2010). Triptolide inactivates Akt and induces caspase-dependent death in cervical cancer cells via the mitochondrial pathway. Int J Oncol, 37, 1177-85.
  16. Landis SH, Murray T, Bolden S, Wingo PA (1999). Cancer statistics, 1999. CA Cancer J Clin, 49, 8-31.
  17. Li B, Takeda T, Tsuiji K, et al (2013). Curcumin induces crossregulation between autophagy and apoptosis in uterine leiomyosarcoma cells. Int J Gynecol Cancer, 23, 803-8.
  18. Li H, Takai N, Yuge A, et al (2010). Novel target genes responsive to the anti-growth activity of triptolide in endometrial and ovarian cancer cells. Cancer Lett, 297, 198-206.
  19. Liu Y, Song F, Wu WK, et al (2012). Triptolide inhibits colon cancer cell proliferation and induces cleavage and translocation of 14-3-3 epsilon. Cell Biochem Funct, 30, 271-8.
  20. Matsui Y, Watanabe J, Ikegawa M, et al (2008). Cancer-specific enhancement of cisplatin-induced cytotoxicity with triptolide through an interaction of inactivated glycogen synthase kinase-3beta with p53. Oncogene, 27, 4603-14.
  21. Muggia F (2009). Platinum compounds 30 years after the introduction of cisplatin: implications for the treatment of ovarian cancer. Gynecol Oncol, 112, 275-81.
  22. Ono M, Higuchi T, Takeshima M, Chen C, Nakano S (2013). Antiproliferative and apoptosis-inducing activity of curcumin against human gallbladder adenocarcinoma cells. Anticancer Res, 33, 1861-6.
  23. Pacak K, Sirova M, Giubellino A, et al (2012). $NF-{\kappa}B$ inhibition significantly upregulates the norepinephrine transporter system, causes apoptosis in pheochromocytoma cell lines and prevents metastasis in an animal model. Int J Cancer, 131, 2445-55.
  24. Phillips PA, Dudeja V, McCarroll JA, et al (2007). Triptolide induces pancreatic cancer cell death via inhibition of heat shock protein 70. Cancer Res, 67, 9407-16.
  25. Qiao Q, Jiang Y, Li G (2013). Inhibition of the PI3K/AKT-$NF-{\kappa}B$ Pathway With Curcumin Enhanced Radiation-Induced Apoptosis in Human Burkitt's Lymphoma. J Pharmacol Sci, 121, 247-56.
  26. Rozzo C, Fanciulli M, Fraumene C, et al (2013). Molecular changes induced by the curcumin analogue D6 in human melanoma cells. Mol Cancer, 12, 37
  27. Schmitt CA, Lowe SW (2001). Apoptosis is critical for drug response in vivo. Drug Resist Updat, 4, 132-4.
  28. Shakibaei M, Mobasheri A, Lueders C, et al (2013). Curcumin enhances the effect of chemotherapy against colorectal cancer cells by inhibition of $NF-{\kappa}B$ and Src protein kinase signaling pathways. PLoS One, 8, e57218.
  29. Tan BJ, Chiu GN (2013). Role of oxidative stress, endoplasmic reticulum stress and ERK activation in triptolide-induced apoptosis. Int J Oncol, 42, 1605-12.
  30. Wang W, Lin W, Hong B, et al (2012). Effect of triptolide on malignant peripheral nerve sheath tumours in vitro and in vivo. J Int Med Res, 40, 2284-94.
  31. Wei X, Zhou D, Wang H, et al (2013). Effects of pyridine analogs of curcumin on growth, apoptosis and $NF-{\kappa}B$ activity in prostate cancer PC-3 cells. Anticancer Res, 33, 1343-50.
  32. Wen L, Chen Y, Zeng LL, et al (2012). Triptolide induces cellcycle arrest and apoptosis of human multiple myeloma cells in vitro via altering expression of histone demethylase LSD1 and JMJD2B. Acta Pharmacol Sin, 33, 109-19.
  33. Yin HT, Zhang DG, Wu XL, Huang XE, Chen G (2013). In vivo evaluation of curcumin-loaded nanoparticles in a A549 xenograft mice model. Asian Pac J Cancer Prev, 14, 409-12.
  34. Yu J, Zhou X, He X, Dai M, Zhang Q (2011). Curcumin induces apoptosis involving bax/bcl-2 in human hepatoma SMMC- 7721 cells. Asian Pac J Cancer Prev, 12, 1925-9.
  35. Zhou B, Huang J, Zuo Y, et al (2013). 2a, a novel curcumin analog, sensitizes cisplatin-resistant A549 cells to cisplatin by inhibiting thioredoxin reductase concomitant oxidative stress damage. Eur J Pharmacol, 707, 130-9.
  36. Zhu W, Hu H, Qiu P, Yan G (2009). Triptolide induces apoptosis in human anaplastic thyroid carcinoma cells by a p53- independent but NF-kappaB-related mechanism. Oncol Rep, 22, 1397-401.

Cited by

  1. Co-treatment of THP-1 cells with naringenin and curcumin induces cell cycle arrest and apoptosis via numerous pathways vol.12, pp.6, 2012,
  2. Association between the HSPA1B ±1267A/G Polymorphism and Cancer Risk: a Meta-analysis of 14 Case-Control Studies vol.15, pp.16, 2014,
  3. Triptolide induces apoptosis of breast cancer cells via a mechanism associated with the Wnt/β-catenin signaling pathway vol.8, pp.2, 2014,
  4. Biological and therapeutic activities, and anticancer properties of curcumin vol.10, pp.5, 2015,
  5. The Inhibition Effect of Triptolide on Human Endometrial Carcinoma Cell Line HEC-1B: a in vitro and in vivo Studies vol.16, pp.11, 2015,
  6. Tumor exosomes: a double-edged sword in cancer therapy vol.39, pp.4, 2018,